Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2012
03/15/2012US20120064033 Modulation of regulatory t cells by human il-18
03/15/2012US20120064032 Novel hydroxamates as therapeutic agents
03/15/2012US20120064031 Cells, nucleic acid constructs, cells comprising said constructs and methods utilizing said cells in the treatment of diseases
03/15/2012US20120064030 Methods of treating nervous system conditions
03/15/2012US20120064029 Compositions for treating nervous system conditions
03/15/2012US20120064028 Pregnancy-Induced Oligodendrocyte Precursor Cell Proliferation Regulated by Prolactin
03/15/2012US20120064010 CCR3 and its Ligands Are Therapeutic and Diagnostic Targets for Neovascular Age-Related Macular Degeneration
03/15/2012US20120064006 Systems and methods for using physiological information
03/15/2012US20120063999 Psca: prostate stem cell antigen and uses thereof
03/15/2012US20120063998 Method for Treating Psoriatic Arthritis by Administering an Anti-IL-12 Antibody
03/15/2012US20120063997 Delivery system with scaffolds
03/15/2012US20120063996 Novel nimesulide compositions
03/15/2012US20120063994 Rtef-1 variants and uses thereof
03/15/2012US20120063993 Therapeutic and diagnostic conjugates for use with multispecific antibodies
03/15/2012US20120060834 Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases
03/15/2012DE102010037469A1 Verfahren zur Reduzierung des Endotoxingehalts in einem kollagenhaltigen Material Process for reducing the endotoxin content in a collagen containing material
03/15/2012DE102006013624B4 Mittel zur Anwendung bei Fructoseintoleranz Means for use in fructose intolerance
03/15/2012CA2814012A1 Modified relaxin polypeptides
03/15/2012CA2813802A1 Single chain relaxin polypeptides
03/15/2012CA2811001A1 Treatment of constipation-predominant irritable bowel syndrome
03/15/2012CA2810998A1 Inhibitors of human ezh2, and methods of use thereof
03/15/2012CA2810851A1 Compositions and methods for the removal of biofilms
03/15/2012CA2810636A1 Ttll4 peptides and vaccines containing the same
03/15/2012CA2810498A1 Maturation of gastrointestinal tract
03/15/2012CA2809203A1 Novel use
03/15/2012CA2806698A1 Dietary supplement and methods of use thereof
03/14/2012EP2428571A1 MicroRNA molecules
03/14/2012EP2428570A1 MicroRNA molecules
03/14/2012EP2428569A1 MicroRNA molecules
03/14/2012EP2428568A1 MicroRNA molecules
03/14/2012EP2428567A1 MicroRNA molecules
03/14/2012EP2428252A1 Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo
03/14/2012EP2428218A1 Modified proteases that inhibit complement activation
03/14/2012EP2428217A1 Composition based on docosahexaenoic acid (dha) for use in the treatment of cystic fibrosis and non-alcoholic hepatic steatosis
03/14/2012EP2428216A2 Methods of treating cancer using IL-21 and monoclonal antibody therapy
03/14/2012EP2428215A1 An angiogenesis inducing agent comprising recombinant gelatin
03/14/2012EP2428125A2 Nutritional formulation with high energy content
03/14/2012EP2427775A1 Peptide ligands of somatostatin receptors
03/14/2012EP2427485A2 Cd133 epitopes
03/14/2012EP2427483A1 Novel heamoglobin and uses thereof
03/14/2012EP2427478A1 Influenza a and b virus replication-inhibiting peptides
03/14/2012EP2427476A1 Beta-hairpin peptidomimetics having cxcr4 antagonizing activity
03/14/2012EP2427475A1 High penetration prodrug compositions of peptides and peptide-related compounds
03/14/2012EP2427215A1 Stable pharmaceutical compositions of peptide derivatized using an oxime linker
03/14/2012EP2427213A2 Alpha thymosin peptides as vaccine enhancers
03/14/2012EP2427210A1 Modulation of inducible nitric oxide (inos) binding to spry domain-containing socs-box peptides (ssb)
03/14/2012EP2427208A1 Fgf21 mutants and uses thereof
03/14/2012EP2427207A2 Fgf21 mutants and uses thereof
03/14/2012EP2427206A1 Novel compositions for treating pseudomonas infection
03/14/2012EP2427205A2 Par2 agonists for use in the treatment or prevention of influenza virus type a infections
03/14/2012EP2427204A1 Melanocortin receptor binding conjugates
03/14/2012EP2427203A2 Anti-il-17f antibodies and methods of use thereof
03/14/2012EP2427167A1 Method and composition for restoration of age-related tissue loss in the face or selected areas of the body
03/14/2012EP2068949B1 Antimicrobial and immunostimulatory system comprising an oxidoreductase enzyme
03/14/2012EP1978995B1 Method for the treatment and/or prophylaxis of multiple sclerosis, and use of erythropoietin for the manufacture of a medicament for the intermittent treatment and/or intermittent prophylaxis of multiple sclerosis
03/14/2012EP1962959B1 Neuropeptide-2 receptor-agonists
03/14/2012EP1910837B1 Methods and compositions for diagnosis and treatment of influenza
03/14/2012EP1633384B1 Stable analogs of glp-1
03/14/2012EP1622939B1 Active variants of the il-18 binding protein and medical uses thereof
03/14/2012EP1519743B1 Use of an interleukin 1 receptor antagonist alone or in combination with pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes
03/14/2012EP1499729B9 Derivatives of the nf-kappab inducing enzyme, their preparation and use
03/14/2012EP1455766B1 Thymosin alpha 1 peptide/polymer conjugates
03/14/2012EP1448984B1 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens
03/14/2012EP1436003B3 Taci-immunoglobulin fusion proteins
03/14/2012CN1558774B Angiotensin peptide-carrier conjugates and uses thereof
03/14/2012CN102378765A Glycosaminoglycan-antagonising mcp-i mutants and methods of using same
03/14/2012CN102378635A Recombinant human albumin-human granulocyte colony stimulating factor for the prevention of neutropenia
03/14/2012CN102378632A Improvement in promotion of healthy catch-up growth
03/14/2012CN102378581A Process for making a milk-based protein hydrolysate
03/14/2012CN102378576A A peg-albumin composition having at least one protected thiol region as a platform for medications
03/14/2012CN102372780A Preparation method and application of anti-human chorionic gonadotropin (hCG) antibody-interleukin 2 (IL2) fusion protein
03/14/2012CN102372779A Camel single domain antibody with allinase activity as well as preparation method and application thereof
03/14/2012CN102372772A Ruditapes philippin RpTNF gene recombinant protein, its preparation and application
03/14/2012CN102372770A Angiogenesis inhibitant, purification method and medicinal composition therewith
03/14/2012CN102372766A O-type foot-and-mouth disease multi-epitope vaccine with cross immunity protective efficiency
03/14/2012CN102372764A Novel peptides as NS3-serine protease inhibitors of hepatitis c virus
03/14/2012CN102370993A Preparation method for novel red blood cell substitute-artificial red blood cell fluorescent nanoparticles
03/14/2012CN102370988A Technology for transferring antitumor medicament with single-wall carbon nanotube and application thereof
03/14/2012CN102370987A Injection liposome entrapping antineoplastic pharmaceutical composition
03/14/2012CN102370985A Purpose of agonist of natriuretic peptide receptor A in pain management
03/14/2012CN102370973A Preparation method for rhesus ovary and ovarian follicle generation model
03/14/2012CN102370972A Compound Chinese medicine composition for treating infectious bronchitis of chicken and preparation method thereof
03/14/2012CN102370971A Compound bee glue composition for treating fowl pox and preparation method thereof
03/14/2012CN102370970A Traditional Chinese medicine compound composition for treating blue ear disease of sows and preparation method thereof
03/14/2012CN102370969A Compound Chinese medicine composition for treating piglet blue ear disease and preparation method thereof
03/14/2012CN102370968A Compound propolis composite for treating chicken infectious laryngotracheitis and preparation method thereof
03/14/2012CN102370967A Novel application of IL-1Ra (interleukin-1 receptor antagonist) and tumor treatment medicinal composition kit thereof
03/14/2012CN102370966A Purpose and pharmaceutical composition of Reg4
03/14/2012CN102370965A Pharmaceutical composition containing pharmaceutically acceptable salts of levoamlodipine and pharmaceutically acceptable salts of perindopril
03/14/2012CN102370964A Application of interleukin receptor antagonist protein to preparation of external use skin preparation
03/14/2012CN102370630A Recombinant human growth hormone (rhGH) long-acting sustained-release microcapsule and preparation method thereof
03/14/2012CN102370624A Exendin-4 sustained release microsphere, its injection and preparation method
03/14/2012CN102370612A Chitosan-monomethoxy polyethylene glycol gel delivery system and preparation method thereof
03/14/2012CN102370611A Temperature-sensitive hydrogel containing exendin-4 and injection thereof
03/14/2012CN101528925B Dbait and uses thereof
03/14/2012CN101519655B Abalone HINT gene and protein and application of same for preparing anticarcinogenic drug
03/14/2012CN101466829B Synthesis of sialic acid in plants
03/14/2012CN101368176B Complex phospho-esterase, extraction method and complex phospho-esterase capsule
03/14/2012CN101318011B Pentapeptide nose spraying agent for thymus gland, preparation method and application thereof
03/13/2012US8133980 Antibodies and functional fragments thereof that specifically bind an RF-amide peptide or a precursor thereof
1 ... 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 ... 3163